1. Academic Validation
  2. Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor

Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor

  • Bioorg Med Chem Lett. 2010 Apr 15;20(8):2408-11. doi: 10.1016/j.bmcl.2010.03.046.
Timothy P Heffron 1 Megan Berry Georgette Castanedo Christine Chang Irina Chuckowree Jennafer Dotson Adrian Folkes Janet Gunzner John D Lesnick Cristina Lewis Simon Mathieu Jim Nonomiya Alan Olivero Jodie Pang David Peterson Laurent Salphati Deepak Sampath Steve Sideris Daniel P Sutherlin Vickie Tsui Nan Chi Wan Shumei Wang Susan Wong Bing-Yan Zhu
Affiliations

Affiliation

  • 1 Discovery Chemistry, Genentech, Inc., South San Francisco, CA 94080, USA. theffron@gene.com
Abstract

Efforts to identify potent small molecule inhibitors of PI3 kinase and mTOR led to the discovery of the exceptionally potent 6-aryl morpholino thienopyrimidine 6. In an effort to reduce the melting point in analogs of 6, the thienopyrimidine was modified by the addition of a methyl group to disrupt planarity. This modification resulted in a general improvement in in vivo clearance. This discovery led to the identification of GNE-477 (8), a potent and efficacious dual PI3K/mTOR Inhibitor.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-11042
    98.75%, PI3K抑制剂